William E. Boden, MD

William E. Boden, MD
Professor of Medicine and Preventive Medicine, University at Buffalo Schools of Medicine and Public Health; Medical Director, Cardiovascular Services, Kaleida Health; Chief of Cardiology, Buffalo General and Millard Fillmore Hospitals, Buffalo, NY; Co-principal Investigator, Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial

Address: William E. Boden, MD, Division of Cardiology, Buffalo General Hospital, SUNY at Buffalo School of Medicine, 100 High Street, Buffalo, NY 14203; e-mail: [email protected]

Dr. Boden has disclosed that he has received consulting fees or honoraria from Abbott Laboratories, Bristol-Myers Squibb, CV Therapeutics, Merck, PDL BioPharma, and Pfizer.

William E. Boden, MD
Professor of Medicine and Preventive Medicine, University at Buffalo Schools of Medicine and Public Health; Medical Director, Cardiovascular Services, Kaleida Health; Chief of Cardiology, Buffalo General and Millard Fillmore Hospitals, Buffalo, NY; Co-principal Investigator, Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial

Address: William E. Boden, MD, Division of Cardiology, Buffalo General Hospital, SUNY at Buffalo School of Medicine, 100 High Street, Buffalo, NY 14203; e-mail: [email protected]

Dr. Boden has disclosed that he has received consulting fees or honoraria from Abbott Laboratories, Bristol-Myers Squibb, CV Therapeutics, Merck, PDL BioPharma, and Pfizer.

William E. Boden, MD
Professor of Medicine and Preventive Medicine, University at Buffalo Schools of Medicine and Public Health; Medical Director, Cardiovascular Services, Kaleida Health; Chief of Cardiology, Buffalo General and Millard Fillmore Hospitals, Buffalo, NY; Co-principal Investigator, Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial

Address: William E. Boden, MD, Division of Cardiology, Buffalo General Hospital, SUNY at Buffalo School of Medicine, 100 High Street, Buffalo, NY 14203; e-mail: [email protected]

Dr. Boden has disclosed that he has received consulting fees or honoraria from Abbott Laboratories, Bristol-Myers Squibb, CV Therapeutics, Merck, PDL BioPharma, and Pfizer.